Celldex Therapeutics (CLDX) PT Raised to $72 at Wells Fargo
Tweet
Share
E-mailGet Alerts CLDX Hot Sheet
Price: $33.51 --0%
Rating Summary:
18 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 4 | Down: 5 | New: 28
Rating Summary:
18 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 4 | Down: 5 | New: 28
Join SI Premium – FREE
Wells Fargo analyst Derek Archila raised the price target on Celldex Therapeutics (NASDAQ: CLDX) to $72.00 (from $48.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Celldex Therapeutics (CLDX) PT Raised to $57 at Morgan Stanley
- On Holding AG (ONON) PT Raised to $40 at Needham, 'Bullish Analyst Day Alleviates Growth-Slowdown Fears'
- The Gym Group PLC (GYM:LN) PT Raised to GBP2.10 at RBC Capital
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
